Kodiak Sciences (KOD) Total Liabilities (2017 - 2026)
Kodiak Sciences (KOD) posted Total Liabilities of $193.9 million for Q1 2026, little changed on a QoQ basis from $194.1 million in Q4 2025, and up 2.56% year-over-year from $189.1 million in Q1 2025.
Kodiak Sciences (KOD) Total Liabilities (2017 - 2026) Analysis & Trends
Kodiak Sciences' Total Liabilities history runs 10 years deep, the most recent figure standing at $193.9 million for Q1 2026.
- Quarterly Total Liabilities rose 2.56% year-over-year to $193.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.9 million (up 2.56% YoY) and the FY2025 annual result came in at $194.1 million, up 4.78% from the prior year.
- Total Liabilities was $193.9 million for Q1 2026 at Kodiak Sciences, roughly flat from $194.1 million in the prior quarter.
- Across five years, Total Liabilities topped out at $252.9 million in Q1 2022 and bottomed at $185.3 million in Q4 2024.
- A 5-year average of $214.6 million and a median of $194.4 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities increased 19.83% — and 2024, when it retreated 25.52%.
- Kodiak Sciences' Total Liabilities stood at $230.5 million in 2022, then dropped by 7.32% to $213.6 million in 2023, then declined by 13.25% to $185.3 million in 2024, then grew by 4.78% to $194.1 million in 2025, then decreased by 0.13% to $193.9 million in 2026.
- Business Quant data shows KOD's Total Liabilities at $193.9 million in Q1 2026, $194.1 million in Q4 2025, and $194.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | 193.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193.91 Mn |
| Dec 31, 2025 | 194.15 Mn |
| Sep 30, 2025 | 194.38 Mn |
| Jun 30, 2025 | 186.44 Mn |
| Mar 31, 2025 | 189.07 Mn |
| Dec 31, 2024 | 185.29 Mn |
| Sep 30, 2024 | 187.30 Mn |
| Jun 30, 2024 | 187.07 Mn |
| Mar 31, 2024 | 193.57 Mn |
| Dec 31, 2023 | 213.59 Mn |
| Sep 30, 2023 | 245.24 Mn |
| Jun 30, 2023 | 251.18 Mn |
| Mar 31, 2023 | 247.75 Mn |
| Dec 31, 2022 | 230.46 Mn |
| Sep 30, 2022 | 244.46 Mn |
| Jun 30, 2022 | 250.97 Mn |
| Mar 31, 2022 | 252.90 Mn |
| Dec 31, 2021 | 240.90 Mn |
| Sep 30, 2021 | 231.89 Mn |
| Jun 30, 2021 | 218.17 Mn |